tiprankstipranks
Trending News
More News >
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market

Assertio Therapeutics (ASRT) Income Statement

Compare
1,159 Followers

Assertio Therapeutics Income Statement

Last quarter (Q4 2025), Assertio Therapeutics's total revenue was $13.54M, a decrease of -57.92% from the same quarter last year. In Q4, Assertio Therapeutics's net income was $-11.06M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 118.71M$ 124.96M$ 152.07M$ 156.23M$ 111.01M
Gross Profit
$ 83.33M$ 85.73M$ 125.05M$ 137.49M$ 95.18M
Operating Expenses
$ 104.87M$ 110.21M$ 368.58M$ 98.08M$ 85.76M
Depreciation and Amortization
$ 30.00M$ 25.83M$ 28.23M$ 33.40M$ 29.11M
EBITDA
$ 16.32M$ 5.15M$ 53.17M$ 90.17M$ 38.78M
Operating Income
$ -21.54M$ -24.48M$ -243.54M$ 39.41M$ 9.42M
Other Income/Expenses
$ -8.40M$ 2.95M$ -10.52M$ -8.24M$ -9.98M
Pretax Income
$ -29.94M$ -21.53M$ -254.05M$ 31.17M$ -553.00K
Net Income
$ -29.50M$ -21.58M$ -331.94M$ 109.63M$ -1.28M
Per Share Metrics
Basic EPS
$ -4.74$ -3.45$ -70.05$ 34.95$ -0.45
Diluted EPS
$ -4.74$ -3.45$ -70.05$ 30.45$ -0.45
Weighted Average Shares Outstanding
6.40M 6.35M 4.74M 3.13M 2.88M
Weighted Average Shares Outstanding (Diluted)
6.40M 6.35M 4.74M 3.64M 2.88M
Currency in USD

Assertio Therapeutics Earnings and Revenue History